| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1256747 | Current Opinion in Chemical Biology | 2014 | 6 Pages |
•Aptamers are nucleic acid ligands capable of high affinity and specificity.•Recent developments enhance prospects for application in diagnosis and therapy.•We examine replication of nucleic acid chemistries with potential applications.•We summarise recent refinements of aptamer selection methodology.
Aptamers are a class of single-stranded nucleic acid ligands that can bind their targets with high specificity and affinities rivalling those of antibodies. First described over 20 years ago by Tuerk & Gold [1] and Ellington & Szostak [2] (who coined the name), their promise as both diagnostic and therapeutic agents remains to be realised. Key problems include the generally low biostability of the standard DNA/RNA or mixed RNA/2′F-DNA backbones under physiological conditions, limited chemical diversity of functional groups on the natural nucleobases, and the difficulty in reliably discovering aptamer ligands to some therapeutic targets.This review will describe recent progress in developing aptamer selection technology as well as expanding aptamer chemistry and informational complexity to improve aptamer discovery and properties.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (139 K)Download as PowerPoint slide
